Product Information
LOREEV XR 2 MG CAPSULE is a brand product labeled by Almatica Pharma LLC, priced at $14.2086 per EA under NDC 52427066330. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application on Aug 27, 2021.
The High Outlier badge above means this manufacturer's average price in the lorazepam market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
2 mg/1
Manufacturer
Almatica Pharma LLCNDC
52427066330
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LORAZEPAMApproval Type
New Drug (NDA)
FDA Application
NDA214826FDA Approved
8/27/2021
On Market Since
8/31/2021
Pharmacological Classes
Price Statistics
The NADAC for LOREEV XR 2 MG CAPSULE has been published 123 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $14.2086 per EA |
|---|---|
| All-time high | $14.2639 (Jul 16, 2025) |
| All-time low | $14.1789 (Apr 17, 2024) |
| 52-week high | $14.2507 |
| 52-week low | $14.2086 |
| Median price | $14.2395 |
| Average price | $14.2361 |
| Largest weekly change | +0.2% (Aug 21, 2024) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the lorazepam market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LOREEV XR 2 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LOREEV XR 2 MG CAPSULE, manufactured by Almatica Pharma LLC, is $14.2086 per EA (NDC 52427066330), effective Aug 19, 2026.
How has the price of LOREEV XR 2 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LOREEV XR 2 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for LOREEV XR 2 MG CAPSULE?
Since Apr 17, 2024, the NADAC for LOREEV XR 2 MG CAPSULE has ranged from a low of $14.1789 (Apr 17, 2024) to a high of $14.2639 (Jul 16, 2025), with a median of $14.2395 per EA.
Are there cheaper alternatives to LOREEV XR 2 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of LOREEV XR 2 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LOREEV XR 2 MG CAPSULE?
LOREEV XR 2 MG CAPSULE (NDC 52427066330) is labeled by Almatica Pharma LLC, and CMS classifies it as a brand product.